Article
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor–Initiating Cells
7 Jul 2015
Abstract excerpt
PURPOSE: Clonal evolution of cancer may be regulated by determinants of stemness, specifically self-renewal, and current therapies have not considered how genetic perturbations or properties of stemness affect such functional processes. Glioblastoma-initiating cells (GICs), identified by expression of the cell surface marker CD133, are shown to be chemoradioresistant. In the current study, we sought to elucidate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
